Cargando…
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease
Autores principales: | Daunt, Anna, Perez-Guzman, Pablo N., Liew, Felicity, Hauck, Katharina, Costelloe, Ceire E., Thursz, Mark R., Cooke, Graham, Nayagam, Shevanthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306204/ https://www.ncbi.nlm.nih.gov/pubmed/32579980 http://dx.doi.org/10.1016/j.jinf.2020.06.049 |
Ejemplares similares
-
Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study
por: Middleton, Paul, et al.
Publicado: (2021) -
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
por: Heffernan, Alastair, et al.
Publicado: (2019) -
The impact of the COVID-19 pandemic on patterns of attendance at emergency departments in two large London hospitals: an observational study
por: Vollmer, Michaela A. C., et al.
Publicado: (2021) -
Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study
por: Perez-Guzman, Pablo N, et al.
Publicado: (2020) -
The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
por: Schmit, Nora, et al.
Publicado: (2020)